HomePUNJABCHEM › Filing
🔔 Get instant alerts when PUNJABCHEM files quarterly results on BSE Start free trial →

Investor Presentation-Financial Overview- Q1 of FY27

Filed: 31 Jul 2026, 13:49 IST Exchange: BSE Category: Financial Results — Investor Presentation
AI summary - Q1FY27 revenue 347 Cr +9% YoY, driven by export sales and 14% contribution from new products growing 40% YoY - Gross margin improved 355 bps YoY to 36.6% due to product mix, efficiency gains, and price increases - EBITDA 41 Cr +18.8% YoY with 11.8% margin from operational efficiencies and refined product portfolio - PAT 22 Cr +7% YoY; PAT margin at 6.4% - New intermediates capacity enhanced; volume growth expected 100% in FY27 - Strategic partnership volumes to start picking up from Q4FY27 - Domestic launch of 2 intermediate herbicides planned in Q3/Q4FY27
Source: Original filing PDF — view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts BOT
🚨 PUNJABCHEM — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
✓✓ 6:47 PM
🎧
Instant audio summaries2-min AI concall recap delivered with every earnings alert
📊
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
🔍
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes

Add PUNJABCHEM to your watchlist — all of this, automated.

Sign in with Google
14-day Pro trial · No credit card · Cancel anytime

More on Punjab Chemicals & Crop Protection Limited

Important. The summary above is generated automatically from Punjab Chemicals & Crop Protection Limited's own public regulatory filing under SEBI LODR. Indian Stock Alerts is not a SEBI-registered Research Analyst or Investment Adviser. This page is informational, not investment advice, a recommendation to buy or sell any security, or any opinion about the company's business, governance or financial health. Always read the original filing before acting and consult a registered adviser for investment decisions.